Clinical Trial

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal impairment or end stage renal disease.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-17
Trial Details
NCT Number NCT07559396
Lead Sponsor Incyte Corporation
Conditions Renal Impairment
Enrollment 16 participants
Start Date 2026-05-29
Primary Completion 2027-01-04 (estimated)
Study Completion 2027-01-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-16